(2-Methyloxazol-4-yl)methanamine
97%
- Product Code: 113141
CAS:
1065073-45-1
| Molecular Weight: | 112.13 g./mol | Molecular Formula: | C₅H₈N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09909579 | |
| Melting Point: | Boiling Point: | 186.3±15.0°C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C, protected from light, stored in an inert gas |
Product Description:
(2-Methyloxazol-4-yl)methanamine is primarily utilized in the field of medicinal chemistry as a key building block for the synthesis of various pharmaceutical compounds. Its structure is often incorporated into molecules designed to interact with biological targets, particularly in the development of drugs targeting the central nervous system. The compound's oxazole ring provides a stable scaffold that can enhance the binding affinity and selectivity of potential drug candidates. Additionally, it is explored in the creation of novel antibiotics and antifungal agents due to its ability to mimic natural bioactive molecules. Researchers also investigate its potential in designing small-molecule inhibitors for enzymes involved in disease pathways, making it a valuable intermediate in drug discovery and development.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $1,495.02 |
+
-
|
(2-Methyloxazol-4-yl)methanamine
(2-Methyloxazol-4-yl)methanamine is primarily utilized in the field of medicinal chemistry as a key building block for the synthesis of various pharmaceutical compounds. Its structure is often incorporated into molecules designed to interact with biological targets, particularly in the development of drugs targeting the central nervous system. The compound's oxazole ring provides a stable scaffold that can enhance the binding affinity and selectivity of potential drug candidates. Additionally, it is explored in the creation of novel antibiotics and antifungal agents due to its ability to mimic natural bioactive molecules. Researchers also investigate its potential in designing small-molecule inhibitors for enzymes involved in disease pathways, making it a valuable intermediate in drug discovery and development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :